Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Novel Therapeutic Target in Leukemia Stem Cells |
Cincinnati Children's Hospital Medical Center / James Mulloy |
Innovation Grants |
2010 |
Ohio |
A novel compound for treatment of T cell leukemia |
Huntsman Cancer Institute / Nikolaus Trede |
Innovation Grants |
2010 |
Utah |
A New York Based Pediatric Oncology Developmental Therapeutics Program |
Columbia University / Julia Glade Bender, MD |
Phase I/II Infrastructure Grants |
2010 |
New York |
The role of PDE4B in Racial Disparities in Outcome of Childhood Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Jun Yang |
Young Investigator Grants |
2010 |
Tennessee |
Characterization and Targeting of Novel Activating BRAF Mutations in Pediatric Brain Tumors |
Children’s Hospital of Philadelphia / Angela Waanders, MD, MPH |
Young Investigator Grants |
2010 |
Pennsylvania |
Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.
|
Huntsman Cancer Institute / Stephen Lessnick |
Innovation Grants |
2009 |
Utah |
Pediatric Oncology Translational Research Program |
Vanderbilt University Medical Center / James Whitlock, M.D. |
Phase I/II Infrastructure Grants |
2009 |
Tennessee |
Identifying Rare Genetic Variants Involved in High Risk Pediatric Leukemia Via Pooled Sequencing |
Washington University / Todd Druley, MD, PhD |
'A' Award Grants |
2009 |
Missouri |
Neuronal Damage, Neurocognitive Losses and Quality of Life Following High-Dose Chemotherapy in Children with Brain Tumors |
Children’s Hospital Los Angeles / Mary Nelson |
Nurse Researcher Grants |
2009 |
California |